✨ Medicines Approval Notices
NEW ZEALAND GAZETTE
No. 136
Health
Medicines Act 1981
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Levothyroxine sodium 0.025 mg, 0.1 mg, 0.15 mg | Tablets | Organon International BV, Oss, The Netherlands | Thyrax Duotab |
Note: Not substitutable with any L-thyroxine sodium product.
This corrects the entry shown in the New Zealand Gazette notice published on 19 August 1993.
Dated this 16th day of August 1993.
C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
GO8087
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Beclamide 330 mg | Tablet | Chemische Fabrik Promonta GmbH, Hamburg, Germany | Neurocèn |
To be prescribed by specialists for conditions refractory to first line therapy.
Dated this 18th day of September 1993.
D. SMYTH, Acting Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
GO8089
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Malathion 0.25% w/w, permethrin 0.50% w/w, piperonyl butoxide 2% w/w, Ofoxacin 0.3% w/v | Topical aerosol spray | Societe de Conception et d'Applications Thérapeutiques, Marseille, France | Para Plus |
| Ofloxacin | Ophthalmic solution | Allergan Pharmaceuticals (Ireland) Limited, Westport, County Mayo, Ireland | Ocuflux |
| Piperacillin sodium 2.085 g equivalent 2 g piperacillin/tazobactam sodium 268.3 mg equivalent 250 mg tazobactam | Powder for reconstitution for IV or IM injection | Lederle Pipecillin Inc., Carolina, Puerto Rico | Tazocin |
| Piperacillin sodium 3.127 g equivalent 3 g piperacillin/tazobactam sodium 402.5 mg equivalent 375 mg tazobactam | Powder for reconstitution for IV or IM injection | ||
| Piperacillin sodium 4.170 g equivalent 4 g piperacillin/tazobactam sodium 536.6 mg equivalent 500 mg tazobactam | Powder for reconstitution for IV or IM injection | ||
| Bleomycin sulphate 15,000 IU | Powder for reconstitution for IV or IM injection | David Bull Laboratories Pty Limited, Mulgrave North, Victoria, Australia | Bleomycin Sulphate injection |
Dated this 16th day of August 1993.
C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1993, No 136
NZLII —
NZ Gazette 1993, No 136
✨ LLM interpretation of page content
🏥 Consent to Distribution of Levothyroxine Sodium Tablets
🏥 Health & Social Welfare16 August 1993
Medicines, Approval, Levothyroxine Sodium, Thyrax Duotab
- C. Lovelace, Director-General of Health
🏥 Provisional Consent to Distribution of Beclamide Tablets
🏥 Health & Social Welfare18 September 1993
Medicines, Provisional Approval, Beclamide, Neurocèn
- D. Smyth, Acting Director-General of Health
🏥 Consent to Distribution of Multiple New Medicines
🏥 Health & Social Welfare16 August 1993
Medicines, Approval, Malathion, Ofloxacin, Piperacillin, Bleomycin Sulphate
- C. Lovelace, Director-General of Health